Correction: MiR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer: [Oncotarget., 7, 18, (2016) (25930-25948)] DOI: 10.18632/oncotarget.8412

Yinghong Pan, Gordon Robertson, Lykke Pedersen, Emilia Lim, Anadulce Hernandez-Herrera, Amy C. Rowat, Sagar L. Patil, Clara K. Chan, Yunfei Wen, Xinna Zhang, Upal Basu-Roy, Alka Mansukhani, Andy Chu, Payal Sipahimalani, Reanne Bowlby, Denise Brooks, Nina Thiessen, Cristian Coarfa, Yussanne Ma, Richard A. MooreJacquie E. Schein, Andrew J. Mungall, Jinsong Liu, Chad V. Pecot, Anil K. Sood, Steven J.M. Jones, Marco A. Marra, Preethi H. Gunaratne

Research output: Contribution to journal › Comment/debate › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Correction: MiR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer: [Oncotarget., 7, 18, (2016) (25930-25948)] DOI: 10.18632/oncotarget.8412'. Together they form a unique fingerprint.